Log in

Relevant bibliographies by topics / Zyprox / Journal articles

To see the other types of publications on this topic, follow the link: Zyprox.

Journal articles on the topic 'Zyprox'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Zyprox.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Gideon, A.Shallangwa, Musa Haliru, and Ogbe Elizabeth. "Design and Synthesis of New Series of One Pot Schiff Bases of 4-AminobenzenesulfonAmideas Potent Antibacterial and Anti-Fungal Agents." Journal of Progressive Research in Chemistry 1, no. 1 (2015): 14–21. https://doi.org/10.5281/zenodo.3970062.

Full text

Abstract:

Schiff bases are imines formed by the condensation of a primary amine and a carbonyl compound. These classes of compounds are very important due to their wide range of biological activities and industrial applications. In this study, some Schiff bases (coded GAS1-5) were synthesized by condensation of 4–Aminobenzenesulfonamide and some selected carbonyl molecules via MW irradiation for 1 minute at 385 watt power; and were characterized by FT-IR and elemental analyses. These Schiff bases were then evaluated for their bactericidal effects against two Gram positive and two Gram negative bac

APA, Harvard, Vancouver, ISO, and other styles

2

Kreys, Tiffany-Jade. "Demystifying Zyprexa Relprevv usage." Mental Health Clinician 1, no. 6 (2011): 121–25. http://dx.doi.org/10.9740/mhc.n89498.

Full text

Abstract:

Zyprexa Relprevv, an extended-release injectable suspension of olanzapine, received FDA approval in December 2009 for the treatment of schizophrenia in adults. Due to the risk of post-injection delirium/sedation syndrome (PDSS) associated with Zyprexa Relprevv usage, the injection is only available through a restricted distribution program. This article reviews the impact of PDSS on the use of Zyprexa Relprevv.

APA, Harvard, Vancouver, ISO, and other styles

3

&NA;. "OLANZAPINE (ZYPREXA)." American Journal of Nursing 97, no. 9 (1997): 59–60. http://dx.doi.org/10.1097/00000446-199709000-00035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Healy, David. "The Zyprexa papers." Psychosis 12, no. 4 (2020): 381–82. http://dx.doi.org/10.1080/17522439.2020.1766547.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Antonuccio, David. "The Zyprexa Papers, by Jim Gottstein." Ethical Human Psychology and Psychiatry 22, no. 2 (2020): 124–25. http://dx.doi.org/10.1891/ehpp-d-20-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Leung, David, Sophie Davies, and Smeeta Wong. "Zyprexa Velotab (olanzapine): suitable for vegetarians?" Psychiatric Bulletin 29, no. 7 (2005): 275–76. http://dx.doi.org/10.1192/pb.29.7.275-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

&NA;. "Zyprexa, Symbyax labelling updated in the US." Reactions Weekly &NA;, no. 1173 (2007): 2. http://dx.doi.org/10.2165/00128415-200711730-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Worthen, Sue T., Jeffrey S. Kasher, John Saunders, et al. "The Global Registration of Zyprexa™ (Olanzapine)." Drug Information Journal 31, no. 1 (1997): 49–55. http://dx.doi.org/10.1177/009286159703100108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Tamminga, Carol A., and John M. Kane. "Olanzapine (Zyprexa):charactirestics of a new antipsychotic." Expert Opinion on Investigational Drugs 6, no. 11 (1997): 1743–52. http://dx.doi.org/10.1517/13543784.6.11.1743.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "Warning added to Zyprexa label regarding hyperglycaemia/diabetes." Inpharma Weekly &NA;, no. 1430 (2004): 21. http://dx.doi.org/10.2165/00128413-200414300-00059.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

&NA;. "Warning added to Zyprexa label regarding hyperglycaemia/diabetes." Reactions Weekly &NA;, no. 994 (2004): 2. http://dx.doi.org/10.2165/00128415-200409940-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Collin, A., D. Clevenot, P. Moulin, C. Macabeo, and J. S. David. "Pancréatite aiguë grave induite par l’olanzapine (Zyprexa®)." Annales Françaises d'Anesthésie et de Réanimation 28, no. 10 (2009): 907–9. http://dx.doi.org/10.1016/j.annfar.2009.09.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Yan, Jun. "Lilly Agrees to Zyprexa Labeling on Glucose-Metabolism Risk." Psychiatric News 42, no. 22 (2007): 5. http://dx.doi.org/10.1176/pn.42.22.0005a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Cary, John H., Becky S. Li, and Howard I. Maibach. "Dorsal hand skin hyperpigmentation following oral olanzapine (Zyprexa) use." Contact Dermatitis 79, no. 4 (2018): 254–55. http://dx.doi.org/10.1111/cod.13059.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

. "1171 Zyprexa®-Slachtoffers Kunnen Aansluiten Bij Amerikaanse Rechtszaak." Zorg en Financiering 6, no. 9 (2007): 107–8. http://dx.doi.org/10.1007/bf03094463.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Cornwall, Michael Warren. "Book Review: The Zyprexa Papers by Gottstein, J." Journal of Humanistic Psychology 62, no. 3 (2021): 433–35. http://dx.doi.org/10.1177/00221678211062718.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Rosack, Jim. "Lilly to Pay Out Millions to Settle Lawsuits Over Zyprexa." Psychiatric News 42, no. 3 (2007): 1–30. http://dx.doi.org/10.1176/pn.42.3.0001a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Wooltorton, E. "Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials." Canadian Medical Association Journal 170, no. 9 (2004): 1395. http://dx.doi.org/10.1503/cmaj.1040539.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Moran, Mark. "Zyprexa IM Caution Issued in Some Countries But Not U.S." Psychiatric News 40, no. 8 (2005): 1–66. http://dx.doi.org/10.1176/pn.40.8.00400001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Joye, F., M. Orrillard, F. Marion, I. Michoux, and R. Parisot. "Intoxication sévère probable par olanzapine (Zyprexa®). Effet bénéfique du glucagon." Annales Françaises d'Anesthésie et de Réanimation 18, no. 6 (1999): 686–90. http://dx.doi.org/10.1016/s0750-7658(99)80158-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Applbaum, Kalman. "Shadow science: Zyprexa, Eli Lilly and the globalization of pharmaceutical damage control." BioSocieties 5, no. 2 (2010): 236–55. http://dx.doi.org/10.1057/biosoc.2010.5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Steinkopf, Signe, Anja Katrin Schelderup, Hanne Linn Gjerde, et al. "The psychotropic drug olanzapine (Zyprexa®) increases the area of acid glycerophospholipid monolayers." Biophysical Chemistry 134, no. 1-2 (2008): 39–46. http://dx.doi.org/10.1016/j.bpc.2008.01.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Hartwig, Jan, Sascha Ceylan, Lukas Kupracz, Ludovic Coutable, and Andreas Kirschning. "Induktives Heizen unter Hochfrequenzbedingungen: Anwendung in der kontinuierlichen Synthese des Neuroleptikums Olanzapin (Zyprexa)." Angewandte Chemie 125, no. 37 (2013): 9995–99. http://dx.doi.org/10.1002/ange.201302239.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Hernandez, Inmaculada, and Yuting Zhang. "Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012." Gerontology and Geriatric Medicine 3 (January 1, 2017): 233372141770494. http://dx.doi.org/10.1177/2333721417704946.

Full text

Abstract:

Objectives: The aim of the study was to examine the trend in incidence and prevalence of dementia, use and spending of antidementia and antipsychotic drugs among dementia patients. Methods: Using 2006-2012 Medicare claims data, we identified individuals with diagnosis of dementia and collected their pharmacy claims in 2006-2012. We built regression models to test the trend in number of prescriptions and spending on antidementia, antipsychotic, and other drugs. Results: The prevalence of dementia did not change during our study period. Spending on antidementia and antipsychotic drugs creased to

APA, Harvard, Vancouver, ISO, and other styles

25

Bridler, R. "Subjektives Erleben junger schizophrener Patienten: Atypisches Antipsychotikum Zyprexa® nicht besser als Haldol®." Praxis 92, no. 45 (2003): 1921–22. http://dx.doi.org/10.1024/0369-8394.92.45.1921.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Trevitt, J. T., B. B. Carlson, and J. D. Salamone. "Behavioral assessment of atypical antipsychotics in rats: studies of the effects of olanzapine (Zyprexa)." Psychopharmacology 145, no. 3 (1999): 309–16. http://dx.doi.org/10.1007/s002130051063.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

&NA;. "Olanzapine [Zyprexa; Eli Lilly] "will remain the gold standard for the treatment of schizophrenia through 2015",." Inpharma Weekly &NA;, no. 1578 (2007): 3. http://dx.doi.org/10.2165/00128413-200715780-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Hartwig, Jan, Sascha Ceylan, Lukas Kupracz, Ludovic Coutable, and Andreas Kirschning. "Heating under High-Frequency Inductive Conditions: Application to the Continuous Synthesis of the Neurolepticum Olanzapine (Zyprexa)." Angewandte Chemie International Edition 52, no. 37 (2013): 9813–17. http://dx.doi.org/10.1002/anie.201302239.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

&NA;. "The FDA and Lilly have notified healthcare professionals that the prescribing information for Zyprexa [olanzapine] has been changed." Reactions Weekly &NA;, no. 1287 (2010): 3. http://dx.doi.org/10.2165/00128415-201012870-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Alastanos, Jennifer N., Devika Suri, Hayato DeLellis, and Andrea Mapugay. "A case report and literature review of olanzapine-associated hyperglycemia with previous history of gestational diabetes." Mental Health Clinician 12, no. 1 (2022): 37–44. http://dx.doi.org/10.9740/mhc.2022.01.037.

Full text

Abstract:

Abstract Background Olanzapine (Zyprexa) package labeling includes a warning for hyperglycemia, stating physicians should consider the risks and benefits when prescribing olanzapine to patients with an established diagnosis of diabetes mellitus or having borderline increased blood glucose levels. A case report of olanzapine-associated hyperglycemia in a patient with a history of gestational diabetes mellitus (GDM) is presented and literature review is discussed. Case Report A 33-year-old female with a past medical history of bipolar disorder, cocaine and amphetamine use disorder, hypertension,

APA, Harvard, Vancouver, ISO, and other styles

31

Makunza, John K. "Performance of high workability plaster mortar for water tanks." International Journal of Engineering, Science and Technology 15, no. 1 (2023): 26–36. http://dx.doi.org/10.4314/ijest.v15i1.3.

Full text

Abstract:

Cement sand mortar is frequently used as water proofing plaster layer for water retaining structures. However, the current practice of using standard mortar for plastering has shown to be infective due to observed leakages and low durability of some water retaining structures. In the effort of solving these problems, materials engineers have used artificial chemicals like Zypex to control leakages and improve durability with some success. This paper reports on a study done to address the use of high workability plaster mortar as a solution to meet serviceability requirements for water retainin

APA, Harvard, Vancouver, ISO, and other styles

32

Devina Sagitania, Agung Frijanto, and Budi Yuwono. "Graves Disease Presenting Psychosis: a Case Report." Jurnal Psikiatri Surabaya 13, no. 1 (2024): 82–86. http://dx.doi.org/10.20473/jps.v13i1.43634.

Full text

Abstract:

Introductions: Graves’ disease is the most common cause of hyperthyroidism. Neuropsychiatric manifestations may occur in thyroid disease. As the premier clinical manifestation of Graves disease, psychosis is highly uncommon; it was reported in 1% of cases. The major neuropsychiatric manifestations of hyperthyroidism are acute psychosis, dementia, apathy, agitation, mania, delusional behavior, and hallucinations, especially in older people. Psychosis is highly rare as the first clinical symptom of a grave disease. Case: A 48-year-old female with grave disease symptoms had been taken to the emer

APA, Harvard, Vancouver, ISO, and other styles

33

Passik, Steven D., Rudolph M. Navari, Sin-Ho Jung, et al. "A Phase I Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients: A Hoosier Oncology Group Study." Cancer Investigation 22, no. 3 (2004): 383–88. http://dx.doi.org/10.1081/cnv-200029066.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

&NA;. "Eli Lilly & Co has issued a 'Dear Healthcare Professional' letter to advise of dispensing and prescribing error reports with Zyprexa and Zyrtec,." Reactions Weekly &NA;, no. 1039 (2005): 3. http://dx.doi.org/10.2165/00128415-200510390-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Hori, Hikaru, Nobuhisa Ueda, Reiji Yoshimura, et al. "Olanzapine orally disintegrating tablets (Zyprexa ZydisR) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: An open-label prospective study." World Journal of Biological Psychiatry 10, no. 4-3 (2009): 741–45. http://dx.doi.org/10.1080/15622970903166312.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Cohen, Michael R. "Action Needed to Prevent Dangerous Zyrtec–Zyprexa Mix-Ups Preventing Parenteral Line Mix-Ups ADD-Vantage Bags are Latex-Free but Vials may Not be." Hospital Pharmacy 37, no. 1 (2002): 21–23. http://dx.doi.org/10.1177/001857870203700103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Cada, Dennis J. "Questions and Answers from the F.I.X./• Phenylpropanolamine (PPA) Withdrawal/• Intralipids and Tubing Changes/• Zyprexa Zydis/• H. Pylori Regimens in Pediatrics/• Vasopressin in ACLS/• MD Handwriting Courses." Hospital Pharmacy 36, no. 3 (2001): 257–62. http://dx.doi.org/10.1177/001857870103600305.

Full text

Abstract:

The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers of The Formulary Monograph Service or you may log on through drugfacts.com. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X.

APA, Harvard, Vancouver, ISO, and other styles

38

Gupta, Arjun, Leonce Nshuti, Udhayvir Singh Grewal, et al. "Limited benefit and high financial burden of drugs used to manage cancer-associated anorexia/cachexia syndrome (CACS)." Journal of Clinical Oncology 39, no. 28_suppl (2021): 55. http://dx.doi.org/10.1200/jco.2020.39.28_suppl.55.

Full text

Abstract:

55 Background: To date, drugs used for CACS have limited efficacy and may have unwanted side effects. Despite this, clinicians commonly prescribe certain drugs for CACS, adding financial burden to patients through out-of-pocket costs near or at the end of life. We sought to describe the range of costs of the multiple drugs commonly used to manage CACS. Methods: We reviewed oncology, nutrition, and supportive care guidelines (ASCO, ESMO, ESPEN, MASCC) and compiled a list of drugs recommended for CACS. We also included drugs commonly used off-label in clinical practice as identified by study aut

APA, Harvard, Vancouver, ISO, and other styles

39

Wilson, Nicholas. "Hyperammonemia and First-Degree Atrio-Ventricular Block in Adult Male from Valproic Acid Toxicity." CNS Spectrums 28, no. 2 (2023): 253–54. http://dx.doi.org/10.1017/s1092852923001967.

Full text

Abstract:

AbstractIntroductionThe purpose of this case study is to review the clinical presentation and medical work of an adult male who experienced symptomatic hyperammonemia and first-degree atrio-ventricular block in the setting of valproic acid toxicity.MethodThis case involves a 28-year-old African American male with a past psychiatric history of bipolar 1 disorder with psychotic features, antisocial personality disorder, PTSD, and ASD, who was psychiatrically hospitalized for mania and psychosis at a large midwestern university hospital. At the time of evaluation in the emergency department, the

APA, Harvard, Vancouver, ISO, and other styles

40

Perdomo, Monica, Daniel Silverman, and Celine Hamilton. "IVIG for Treatment-Resistant Psychosis For a Child with Turner Syndrome." CNS Spectrums 28, no. 2 (2023): 249. http://dx.doi.org/10.1017/s1092852923001888.

Full text

Abstract:

AbstractPsychosis is defined as the presence of false beliefs or false perceptions. In children some causes of psychosis include psychiatric diagnosis such as schizophrenia and autism. However, it may also be secondary to medical conditions like various forms of encephalitis. Studies have shown that IVIG has been efficacious in the treatment of psychosis in the setting of autoimmune encephalitis.A 9-year-old girl with a past medical history of Turner Syndrome, developmental delay, epilepsy, growth hormone deficiency, metabolic bone disease, and autism (ASD) presented with auditory and visual h

APA, Harvard, Vancouver, ISO, and other styles

41

Bysani, Sailaja, Jusleen Kendhari, and Cale Robert. "181 Triple Trouble: A Rare Case Report of PCDH19, Autism and Epilepsy in a 7-Year-Old Male Child." CNS Spectrums 23, no. 1 (2018): 104. http://dx.doi.org/10.1017/s1092852918000639.

Full text

Abstract:

AbstractBackgroundA 7-year-old Caucasian male presented to the emergency department with worsening aggression andbehavioral problems. He was diagnosed with seizure disorder at 9 months old and was started on Keppra. He also had delayed developmental milestones including failure to roll until 6 months, and failure to crawl until after 9 months. At 16 months he was aggressive towards other children including unprovoked attacks of biting and assault. When he was 6yrs old he underwent genetic testing which showed positive for PCDH19 mutation. The most consistent feature of this condition is the ea

APA, Harvard, Vancouver, ISO, and other styles

42

McNally, Hannah, Luke Mountjoy, and Alison Collings. "Is There a Higher Incidence of Graft Failure or Delayed Time to Engraftment in Patients Undergoing Autologous Stem Cell Transplantation Who Receive Olanzapine for Anti-Emetic Prophylaxis?" Blood 138, Supplement 1 (2021): 4905. http://dx.doi.org/10.1182/blood-2021-145062.

Full text

Abstract:

Abstract Olanzapine has been shown to significantly decrease nausea and emetic episodes associated with chemotherapy in patients undergoing hematopoietic stem cell transplant (Monson, Greer, Kreikemeier, & Liewer, 2020). Additionally, Olanzapine has been shown to improve clinical outcomes in autologous stem cell transplant patients when added to triplet anti-emetic therapy of ondansetron, fosaprepitant and dexamethasone without any negative effects on time to engraftment (Clemmons, et al., 2018). Although this study did not show any delay in time to engraftment, there is only a small amoun

APA, Harvard, Vancouver, ISO, and other styles

43

Gideon, A.Shallangwa, Musa Haliru, Ogbe Elizabeth, and http://scitecresearch.com/journals/index.php/jprc/article/view/157. "Design and Synthesis of New Series of One Pot Schiff Bases of 4-Aminobenzenesulfon- Amideas Potent Antibacterial and Anti-Fungal Agents." Journal of Progressive Research in Chemistry 1, no. 1 (2015). https://doi.org/10.5281/zenodo.20703.

Full text

Abstract:

Schiff bases are imines formed by the condensation of a primary amine and a carbonyl compound. These classes of compounds are very important due to their wide range of biological activities and industrial applications. In this study, some Schiff bases (coded GAS1-5) were synthesized by condensation of 4–Aminobenzenesulfonamide and some selected carbonyl molecules via MW irradiation for 1 minute at 385 watt power; and were characterized by FT-IR and elemental analyses. These Schiff bases were then evaluated for their bactericidal effects against two Gram positive and two Gram negative bac

APA, Harvard, Vancouver, ISO, and other styles

44

Ken, Davids. "An Antipsychotic." August 6, 2020. https://doi.org/10.5281/zenodo.3974403.

Full text

Abstract:

<strong>Zyprexa </strong>is a trade name of a typical antipsychotic medication called Olanzapine. No one knows how it works. It works by changing some actions of the chemicals on the brain. <strong>Zyprexa</strong> is mainly used to treat psychotic conditions like maniac depression which is also called a bipolar disorder and schizophrenia. This medication is given to adults and also to children who are 13 years or more. Sometimes, <strong>Zyprexa</strong> is used with other antipsychotic medications and antidepressants. It may be also used for treating some other medical conditions. <strong>Im

APA, Harvard, Vancouver, ISO, and other styles

45

"Lilly holds onto Zyprexa patent." Nature Reviews Drug Discovery 4, no. 6 (2005): 450. http://dx.doi.org/10.1038/nrd1758.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Vaidyula, Deepak, and Jothsna Kethar. "Characteristics of Psychotic Depression in Juveniles and Analyzing 4 Antipsychotics." Journal of Student Research 11, no. 4 (2022). http://dx.doi.org/10.47611/jsrhs.v11i4.3486.

Full text

Abstract:

This research paper attempts to answer how psychotic depression differs in children and adults and focuses on the properties of the following four antipsychotics: Mellaril, Clozaril, Zyprexa, and Abilify to analyze which antipsychotic was most effective. This research paper analyzed differences in how children and adults react to psychotic depression by analyzing a recent study. To compare the different drugs, one or more studies were analyzed for each drug, and each drug’s properties were analyzed. After evaluating the different effects of psychotic depression, it was found that hallucination

APA, Harvard, Vancouver, ISO, and other styles

47

"L’olanzapine (zyprexa®) disponible en injectable." PSN 1, no. 5 (2003): 53. http://dx.doi.org/10.1007/bf03005195.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

"US FDA reviews deaths following Zyprexa Relprevv therapy." Reactions Weekly 1545, no. 1 (2015): 8. http://dx.doi.org/10.1007/s40278-015-9099-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

"Vital Signs: Zyprexa Sales Led Antipsychotic Market in 2004." Clinical Psychiatry News 33, no. 7 (2005): 1. http://dx.doi.org/10.1016/s0270-6644(05)70489-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Muhareni, Desweri. "Analisis Minimalisasi Biaya Terapi Olanzapin Injeksi dan Kombinasi Haloperidol Dengan Diazepam Injeksi Pada Pasien Skizofrenia." Jurnal Ayurveda Medistra 4, no. 2 (2023). http://dx.doi.org/10.51690/medistra-jurnal123.v4i2.66.

Full text

Abstract:

Prevalensi skizofrenia mengalami peningkatan yang signifikan dari tahun 2013 ke tahun 2018. Pada 2018, pasien skizofrenia menunjukkan peningkatan 7 per 1.000 penduduk dan sekitar 84,9% mendapatkan obat. Pasien skizofrenia harus mengkonsumsi obat yang dibutuhkan sepanjang hidupnya dan konsultasi rutin dengan psikolog maupun psikiater. Pengeluaran biaya BPJS kesehatan mengalami peningkatan yang signifikan untuk biaya rawat inap dan rawat jalan pasien skizofrenia. Terapi pasien skizofrenia fase akut dapat diberikan olanzapin injeksi (Zyprexa®) atau kombinasi haloperidol injeksi (Lodomer®) dan dia

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!